Genetic Medicine Research Group focuses on research in the areas of human medical genetics by applying advanced molecular and cellular techniques to discover and understand the role of genetic components that are responsible in disease development, progression and deterioration. The group consists of 6 principal investigators with approximately 20 active research personnel. The group works closely with clinicians to screen for genetic variants and their association with disease prevalence, progression and treatment outcomes. The long-term objective of the group is to be able to improve existing molecular diagnoses and treatment modalities for patients suffering from genetic disorders. The group currently embarks in studies related to gene therapy, neurodevelopment, Down syndrome, thalassemia and genetics of breast as well as bladder cancers.